GeneDx Holdings Corp. Cash Flow-to-Debt Ratio
GeneDx Holdings Corp. cash flow-to-debt ratio. GeneDx Holdings Corp. (WGS) has a Cash Flow-to-Debt Ratio of -0.12x as of June 2026, meaning its operating cash flow of $-28.98 Million could theoretically repay 0% of its total liabilities ($237.26 Million) in one year. Check GeneDx Holdings Corp. (WGS) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of GeneDx Holdings Corp. (2020–2025)
Cash flow-to-debt ratio of GeneDx Holdings Corp. from 2020 to 2025. Historical debt coverage capacity for GeneDx Holdings Corp. across 6 annual periods. Check GeneDx Holdings Corp. cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
GeneDx Holdings Corp. Cash Flow-to-Debt Ratio by Year (2020–2025)
GeneDx Holdings Corp. cash flow-to-debt ratio by year from 2020 to 2025. Year-by-year debt coverage analysis for GeneDx Holdings Corp.. For the full cash flow conversion analysis, see WGS cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.13x | $33.28 Million | $262.01 Million | ▲ +177.6% |
| 2024 | -0.16x | $-28.50 Million | $174.13 Million | ▲ +82.7% |
| 2023 | -0.94x | $-180.15 Million | $190.74 Million | ▲ +13.7% |
| 2022 | -1.09x | $-319.15 Million | $291.56 Million | ▲ +4.6% |
| 2021 | -1.15x | $-190.43 Million | $165.99 Million | ▼ -204.6% |
| 2020 | -0.38x | $-93.13 Million | $247.25 Million | — |